Healthcare & Life Sciences
Allgenesis Biotherapeutics, Inc
United States
About
A clinical-stage biotech company focused on discovery and development of small molecules and biologics for ophthalmological diseases, with a pipeline including treatments for diabetic macular edema, wet age-related macular degeneration, pterygium, and dry eye disease.
Explore Allgenesis Biotherapeutics, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.